title: Juvenile dermatomyositis with a rare and remarkable complication: sinus bradycardia.
abstract: Juvenile dermatomyositis (JDM) is characterized by proximal muscle weakness, vasculopathy of the skin and muscles, and typical skin rash. Approximately, 70% of adult patients with dermatomyositis have evidence of cardiac damage. However, cardiac involvement, one of the important causes of death, has been reported rarely in children with JDM. Here, we describe an 11-year-old boy who presented with bradycardia as a result of sinus node involvement due to JDM and recovered by the treatment of JDM without any specific drug for bradycardia.
authors.affiliation: Department of Pediatrics, Faculty of Medicine, The Medical School, Ege University, Bornova, 35100 Izmir, Turkey.
authors.forename: Neslihan Edeer
authors.initials: NE
authors.lastname: Karaca
authors.forename: Guzide
authors.initials: G
authors.lastname: Aksu
authors.forename: Betul Sozeri
authors.initials: BS
authors.lastname: Yeniay
authors.forename: Necil
authors.initials: N
authors.lastname: Kutukculer
mesh_terms: D018501:Antirheumatic Agents / Q000627:therapeutic use; D001919:Bradycardia / Q000188:drug therapy / Q000209:etiology*; D002648:Child; D003882:Dermatomyositis / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007155:Immunologic Factors / Q000627:therapeutic use; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D008775:Methylprednisolone / Q000627:therapeutic use; D012849:Sinoatrial Node / Q000187:drug effects / Q000503:physiopathology*
chemical_list: D018501:Antirheumatic Agents; D016756:Immunoglobulins, Intravenous; D007155:Immunologic Factors; D008775:Methylprednisolone; D008727:Methotrexate